Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A Overview

Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A Research & Development

Research & Development expenses for SLHGP.

Quarterly R&D Expenses

N/A

As of Jun 30, 2022

Annual R&D Expenses (TTM)

N/A

Trailing 12 months ending Jun 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin